跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 114,700 条关于
“focal cortical dysplasia type 2”
全部
114,700
临床试验
88,716
药物
7,758
机构
1,440
资讯
16,786
前天
Sovargen Doses First Patient in Phase 1b/2a Trial of Kazia's Paxalisib for FCD T2 and TSC Epilepsy
2个月前
Single-Nucleus Transcriptomics-Based Drug Screening Platform Identifies Candidate Compounds for Focal Cortical Dysplasia
16天前
PannTheraPi Receives ANSM Approval to Advance First-in-Class Panx1-Targeting Therapy PTI5803 into Phase 2a in Focal Cortical Dysplasia
去年
Angelini Pharma Secures Exclusive Option for Sovargen's Novel Brain Health Asset SVG105
5个月前
PannTheraPi Advances Phase 2a Trial for Rare Epilepsy Drug PTI5803 Targeting Pannexin 1 Channel
去年
PannTheraPi Advances PTI5803 to Phase IIa Trial for Drug-Resistant Epilepsy
15天前
PannTheraPi receives French ANSM nod to advance PTI5803 into Phase 2a trial
去年
GRIN Therapeutics Initiates Radiprodil Trial for Seizures in TSC and FCD
9个月前
Researchers Develop Novel Ethyl Cellulose Injection System for Cervical Dysplasia Treatment
5个月前
Burosumab Shows Dramatic Mobility Gains in Children with Severe Fibrous Dysplasia
第 1 页，共 1679 页
上一页
下一页
